首页> 外文期刊>Retina >RANIBIZUMAB PLUS PROMPT OR DEFERRED LASER FOR DIABETIC MACULAR EDEMA IN EYES WITH VITRECTOMY BEFORE ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY
【24h】

RANIBIZUMAB PLUS PROMPT OR DEFERRED LASER FOR DIABETIC MACULAR EDEMA IN EYES WITH VITRECTOMY BEFORE ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY

机译:RANIBIZUMAB PLUS预防或治疗延缓眼部血管内皮细胞生长因子的糖尿病性黄斑水肿的延迟激光

获取原文
获取原文并翻译 | 示例
           

摘要

Background: The approach to managing diabetic macular edema in eyes with previous vitrectomy is based on limited evidence. Therefore, an exploratory post hoc assessment of 3-year data from eyes with and without vitrectomy before randomization in a DRCR. net trial that evaluated ranibizumab + prompt or deferred laser for diabetic macular edema is presented.
机译:背景:以前的玻璃体切割术治疗眼睛黄斑水肿的方法基于有限的证据。因此,在DRCR中随机分组之前,对有无玻璃体切除术的眼睛的3年数据进行了事后评估。提出了评估兰尼单抗+快速或延迟激光治疗糖尿病性黄斑水肿的网络试验。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号